Skip to content
WeighLab

Next Vial vs MaxLife

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Next Vial

Provider comparison

Shoppers who want a named pharmacy partner and verified LegitScript status without a membership fee.

Semaglutide / month
$199/moMonth-to-month, all doses, compounded
Tirzepatide / month
$249/moMonth-to-month, all doses, compounded
Index 76/100 · Grade CChecked October 2026

MaxLife

Provider comparison

Shoppers comparing a month-to-month GLP-1 plan with a discounted three-month introduction.

Semaglutide / month
$155/moMonth to month; discounted 3-month starter available, compounded
Tirzepatide / month
$195/moMonth to month; discounted 3-month starter available, compounded
Index 76/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 76/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

Next Vial
49 states
MaxLife
All 50 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Next Vial

MaxLife

Semaglutide / month
Next Vial: $199/moMonth-to-month, all doses, compounded
MaxLife: $155/moMonth to month; discounted 3-month starter available, compounded
Tirzepatide / month
Next Vial: $249/moMonth-to-month, all doses, compounded
MaxLife: $195/moMonth to month; discounted 3-month starter available, compounded
Semaglutide / year (modeled)
Next Vial: $2,388
MaxLife: $1,860
Tirzepatide / year (modeled)
Next Vial: $2,988
MaxLife: $2,340
State availability
Next Vial: 49 states
MaxLife: All 50 states
Oral / sublingual option listed
Next Vial: Not listed
MaxLife: Not listed
Brand-name access listed
Next Vial: Not confirmed
MaxLife: Not confirmed
Provider facts checked
Next Vial: October 2026
MaxLife: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Next Vial

Shoppers who want a named pharmacy partner and verified LegitScript status without a membership fee.

Reasons to consider it

  • Names Manifest Pharmacy as a dispensing partner
  • Displays a LegitScript verification link
  • Publishes a 49-state coverage list, excluding Alaska

What to weigh up

  • The lowest advertised monthly equivalents require paying for a longer supply up front
  • The page headline differs from the actual plan selector, so use the selected plan total
  • No individual medical director is named

MaxLife

Shoppers comparing a month-to-month GLP-1 plan with a discounted three-month introduction.

Reasons to consider it

  • Standing monthly rates are published alongside Starter Kits: $267 for three semaglutide months or $360 for three tirzepatide months, then the regular monthly rate
  • The FAQ says all fifty states are served and names dispensing partners including Southend, Red Rock and Hallandale
  • Medication, supplies and priority shipping are included, with provider messaging and dose reviews

What to weigh up

  • The lowest advertised prices require a three-month Starter Kit paid upfront; renewal is $155 for semaglutide or $195 for tirzepatide
  • Cancellation requires at least thirty days of notice, and medication costs are non-refundable
  • No dose-by-dose price ladder or named medical director is published; ask whether a higher dose changes the membership price

Regulatory note: the FDA issued a warning letter to MaxLife Technologies Inc. dba Maxlife in February 2026. We still list and link to MaxLife; you should know the letter is on the public record before you decide.

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Next VialMaxLife
Normalized Cost/Month
Next Vial:
68/100
MaxLife:
74/100
Price Transparency
Next Vial:
97/100
MaxLife:
92/100
Nationwide Access
Next Vial:
78/100
MaxLife:
86/100
Formulation Options
Next Vial:
66/100
MaxLife:
66/100
Clinical Oversight
Next Vial:
82/100
MaxLife:
75/100
Contract Flexibility
Next Vial:
55/100
MaxLife:
53/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.